|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J Thorac Cardiovasc Surg 2008;135:718
© 2008 The American Association for Thoracic Surgery
Letter to the Editor |
Department of Thoracic and Vascular Surgery, University Hospital of Antwerp, Antwerp, Belgium
| The first 20% of the full text of this article appears below. |
To the Editor:
I read with great interest the recent article of the Toronto group on improved results of induction chemoradiation followed by surgery for selected patients with stage IIIA-N2 non–small cell lung cancer.1
Uy and colleagues1
are to be congratulated for their detailed analysis and honest data reporting regarding this difficult subset of patients with N2 disease for whom the optimal treatment remains to be defined. As in the Intergroup-0139 trial,2
Uy and colleagues1
adopted an induction therapy of concurrent
This article has been cited by other articles:
![]() |
A. Brunelli, A. Charloux, C. T. Bolliger, G. Rocco, J-P. Sculier, G. Varela, M. Licker, M. K. Ferguson, C. Faivre-Finn, R. M. Huber, et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Eur. Respir. J., July 1, 2009; 34(1): 17 - 41. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |